Aim: In this study, it was aimed to investigate of the clinical efficacy of melatonin treatment on neuropsychiatric symptoms in elderly patients with hypothyroidism. Method: The study was conducted on 51 patients with hypothyroidism. The patients’ anxiety, depressive symptoms and sleep disturbance were recorded with the Hospital Anxiety and Depression Scale (HADS). The Patients were randomized into two groups. The first group of patients (25 patients) received standard replacement therapy with L-thyroxine and symptomatic therapy for 1 month. The second group of patients (26) received melatonin at a dose of 15 mg per night for 1 month (combination therapy) along with L-thyroxine. Results: There was a significant decrease in TSH levels after therapy in both groups. The decrease was more in the group who received combination therapy (82,2 ± 1,5% versus 66,1 ± 2,4%, respectively). Depressive state was significantly reduced only in the combination therapy group (10,9 ± 0,9 points versus 6,9 ± 0,5 points). Furthermore, in patients receiving melatonin there was a significant reduction in subclinical depression (13,2 ± 3,4% versus 7,7 ± 1,1%, p<0,05). Conclusion: Addition of melatonin to the standard therapy is effective in controlling depressive symptoms in patients with hypothyroidism living in Kazakhstan
Amaç: Bu çalışmanın amacı melatonin tedavisinin yaşlı hipotiroidili hastaların araştırmaktır. Metot: Hipotiroidili 51 hasta çalışmaya alındı. Hastaların depresyon ve anksiyete skorları ve uyku bozukluğu derecesi “Hastane Anksiyete Depresyon Skalası” (HADS) skalası ile değerlendirildi. Hastalar bir ay süreyle L-tiroksin ve melatonin+ L-tiroksin tedavilerine randomize edildiler. Bulgular: Tedavi sonrası kombinasyon tedavisi alan gurupta daha fazla olmak üzere her 2 grupta TSH seviyeleri geriledi (%82,2±1,5’ ye karşılık %66,1±2,4). Depressif durum kombinasyon tedavisi alan gurupta anlamlı olarak azaldı (10,9±0,9 puana karşılık 6,9±0,5 puan). Ayrıca kombinasyon tedavisi alan grupta subklinik depresyon oranı azaldı (%13,2±3,4’ ye karşılık %7,7±1,1) Sonuç: Kazakistan’da yaşayan hipotiroidili hastalarda standart tedaviye melatonin eklenmesi hastaların depressif semptomlarını kontrol altına almada etkilidir
Primary Language | Turkish |
---|---|
Journal Section | Articles |
Authors | |
Publication Date | April 1, 2013 |
Published in Issue | Year 2013 Volume: 5 Issue: 1 |